Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
149
Endocarditis II: Clinical features and Diagnostic Tests01:25

Endocarditis II: Clinical features and Diagnostic Tests

2
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

341
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

148
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
148

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DHDDS-related juvenile parkinsonism is caused by impaired lipid metabolism, glycosylation, and mitochondrial dysfunction, which can be rescued by NAD⁺ treatment.

medRxiv : the preprint server for health sciences·2026
Same author

Ocular involvement in toxic epidermal necrolysis syndrome at Chelsea and Westminster Hospital: a 10-year retrospective analysis and review of current literature.

Eye (London, England)·2026
Same author

Epidemiological Characteristics of the Spine Tumors in a Single Tertiary Centre of Nepal.

Kathmandu University medical journal (KUMJ)·2026
Same author

Knowledge, Attitude and Practice Towards Antimicrobial Resistance and Antimicrobial Adherence among Female Community Health Volunteers Before and After an Educational Intervention.

Kathmandu University medical journal (KUMJ)·2026
Same author

Nonsyndromic Complete Second Branchial Cleft Fistulas: A Clinicosurgical Experience.

Kathmandu University medical journal (KUMJ)·2026
Same author

Phase II Open-Label Randomised Controlled Trial Comparing Oxaliplatin and Cisplatin Based Concurrent Chemoradiotherapy in Locally Advanced Head and Neck Cancers.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

相关实验视频

Updated: Jun 12, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.2K

瓦尔酸盐治疗后的指甲变化

S Shrestha1, A Pandey2, R Pathak3

  • 1Department of Dermatology, Rapti Province Hospital, Dang, Tulsipur, Nepal.

Kathmandu University medical journal (KUMJ)
|September 27, 2024
PubMed
概括
此摘要是机器生成的。

用于和情绪障碍的瓦尔酸很少会导致指甲变色和粗等变化. 这些罕见的指甲副作用在停止服用药物后是可逆的.

更多相关视频

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K
Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
05:33

Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture

Published on: August 4, 2023

1.3K

相关实验视频

Last Updated: Jun 12, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.2K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K
Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
05:33

Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture

Published on: August 4, 2023

1.3K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 皮肤病学 皮肤病学
  • 临床医学 临床医学

背景情况:

  • 瓦尔酸是治疗,双相情感障碍和偏头痛的常见药物.
  • 瓦尔酸的副作用得到了充分的证据,但指甲变化很少被报告.
  • 关于氨酸诱导的指甲异常现有的文献是有限的.

研究的目的:

  • 为了记录和描述与酸 (酸) 使用相关的指甲变化.
  • 为了确定这些指甲变化是否依赖于剂量或与治疗持续时间有关.
  • 评估氨酸诱导的指甲异常的可逆性.

主要方法:

  • 对临床病例的审查报告在酸治疗期间指甲变化.
  • 临床检查和指甲异常的摄影记录.
  • 分析患者数据,包括患者的年龄,剂量和治疗时间.

主要成果:

  • 据报道的指甲变化包括色,色,指甲粗,棕黄色变色和横向黄色带.
  • 这些指甲异常发生不论患者的年龄,酸剂量或治疗持续时间.
  • 在报告的病例中,在停止使用瓦尔酸后,指甲的变化消失了.

结论:

  • 瓦尔酸很少会导致指甲变化的频谱.
  • 这些指甲变化的发生与已确定的药理动力学因素 (如剂量或持续时间) 无关.
  • 迅速识别和停止使用烯酸会导致指甲异常的逆转.